p03277
Small moleculeexperimentalImaging agent
Clinical trial activity
6 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Nov 25, 2013 (NCT03603106)
Timeline
Indications
Mechanism of action
- Unspecified targetContrast agent
contrast agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- p03277
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03749252 | Phase 2 | Nov 6, 2018 | Guerbet, Instytut Pomnik Centrum Zdrowia Dziecka |
| NCT03657784 | Phase 1 | Oct 13, 2017 | Carol Davila University of Medicine and Pharmacy, Guerbet |
| NCT03657264 | Phase 1 | Aug 21, 2017 | Guerbet, SGS Life Sciences |
| NCT02973516 | Phase 2 | Dec 1, 2016 | Guerbet |
| NCT02633501 | Phase 2 | Jun 1, 2016 | Guerbet |
| NCT03603106 | Phase 1/Phase 2 (Phase 2) | Nov 25, 2013 | Guerbet, SGS Life Sciences |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guerbet | For profit | 6 | 6 | 2 | 2013 |
| SGS Life Sciences | For profit | 2 | 0 | 2 | 2013 |
| Carol Davila University of Medicine and Pharmacy | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Instytut Pomnik Centrum Zdrowia Dziecka | Academic/Hospital | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1